The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Zhang, Guoquan
Funded by
NIH Natl Inst of Allergy/Infectious Dise
Coxiella burnetii is an obligate intracellular Gram-negative bacterium that causes acute and chronic Q fever in humans. It is an understudied category B select agent and can be transmitted via aerosol. The existing formalin-inactivated phase I whole-cell vaccine (PIV) induces serious side effects in previously sensitized individuals and no vaccine is commercially available for prevention of human Q fever in the US. Therefore, creation of a safe and effective vaccine to prevent Q fever remains an important public health and national biosecurity goal.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Patterson, Jean L.
Funded by
National Institutes of Health
Collaborating Institutions
University of California Santa Cruz
18-150 The goal is to send inactivated Zika virus infection of marmosets for analysis using nanotechnology. Role: Sub PI
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Schlesinger, Larry S
Funded by
National Institutes of Health
The role of macrophage nuclear receptors in tuberculosis.
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Bach, Stephan
Funded by
US Dept of Agriculture
Objective: Analyze doramectin levels in serum samples from cattle treated in the field to study the interaction between a 1% doramectin product and Bm86 vaccination against fever ticks. Approach: Blood samples collected during the field study will be processed at the USDA, ARS, Cattle Fever Tick Research Laboratory (CFTRL) to obtain serum. ARS will provide the serum samples to The University of Texas at San Antonio (UTSA) to conduct the analysis per the one year field study as detailed below. The serum samples will be shipped to UTSA for analysis to determine doramectin levels.
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Bach, Stephan
Funded by
US Dept of Agriculture
Objective:
Complete concentration analysis of eprinomectin in serum obtained from blood samples collected at the USDA, ARS, Cattle Fever Tick Research Laboratory (CFTRL) in collaboration with the ARS scientists in support of the continuation of research studying the interaction between the Bm86 vaccine and a long-acting eprinomectin injectable formulation.
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Eppinger, Mark
Funded by
Natl Inst of Health
Enterohemorrhagic Escherichia coli (EHEC) of the O157:H7 serotype are notorious for the producing highly potent Shiga toxin. which is a direct mediator of life-threatening global human disease. In this proposal.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Patterson, Jean L.
Funded by
Congressionally Directed Medical Research Program
The goal is to Develop treatments for Zika infection during pregnancy using a marmoset model.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Giavedoni, Luis D.
Funded by
National Institutes of Health
HIV is a major worldwide challenge that remains to be solved, and there is a continuous need to identify improved preventative and therapeutic interventions. This annual symposium provides an environment that promotes the exchange of ideas and perspectives, and fosters new collaborations, especially between junior and senior members of the research community.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Kaushal, Deepak
Funded by
National Institutes of Health
The major goal is to assess the ability of Mtb-specific CD4 T cells from ART versus ART + IPT animals to active antimicrobial functions of Mtb-infected macrophages. Role: PI